In the proposed trial Hemopure will be studied for make use of in the treating life-threatening anemia secondary to induction chemotherapy in individuals with severe myeloid leukemia who refuse red bloodstream cell transfusion. Related StoriesPenn research forms basis for brand-new treatment methods for Sezary syndromePotential fresh drug target for severe myeloid leukemiaBlocking the creation of CHD4 protein can help increase efficiency of AML treatmentsAs previously reported, the business fulfilled with the FDA in July 2008 to go over an acceptable patient human population for a fresh clinical trial. In those days the business proposed a trial in AML sufferers who’ll not accept bloodstream transfusions and consequently cannot undergo possibly life-saving induction chemotherapy due to the profound anemia the chemotherapy causes..

Cianna Medical launches SAVI Sisters program to teach about breast cancer treatment options Cianna Medical, Inc. SAVI delivers a form of therapy referred to as accelerated partial breasts irradiation , a shortened span of high-dose radiation for early-stage breasts cancer patients following lumpectomy surgery. By specifically targeting radiation where the cancer is most probably to recur, SAVI reduces treatment time from six weeks to simply five days. ‘As a women’s health company, we are passionate about making sure women are aware of the many possibilities to take care of early-stage breast cancer, including APBI,’ said Brian Driscoll, Vice President of Marketing at Cianna Medical. ‘We created SAVI Sisters so that women have a location to share their stories, along with provide a discussion board for those who are focused on spreading the term about the options women have with regards to breast malignancy treatment.’ An essential component of the program is the SAVI Sisters website.